Results 181 to 190 of about 92,352 (267)

Performance evaluation of rapid diagnostic tests for Chagas disease in Jutiapa, Guatemala. [PDF]

Rev Soc Bras Med Trop
Lange K, Marchiol A, Herazo R, Menes M, Monroy C, Rodas A, Alcántara B, Carrillo K, Pinazo MJ.   +8 more
europepmc   +1 more source

HLA‐B Serine 116 Confers Protection Against Severe COVID‐19 in a Cohort From Rio de Janeiro, Brazil

HLA, Volume 106, Issue 6, December 2025.
ABSTRACT COVID‐19 is a respiratory disease caused by SARS‐CoV‐2, in which severe outcomes are primarily driven by an exacerbated immune response. The HLA region has been extensively investigated in COVID‐19 due to its central role in the immune response, although genetic associations vary across populations.
Maria Aparecida da Silva Pereira, Sâmila Natiane Ferreira, Cássia Cristina Alves Gonçalves, Mirella Carneiro dos Reis, Carolina da Paz Zampier, Isabela de Carvalho Leitão, Monique de Souza Almeida Lopes, Artur Duque Rossi, Sheila Coelho Soares‐Lima, Rafael Mello Galliez, Shana Priscila Coutinho Barroso, Orlando da Costa Ferreira Junior, Amilcar Tanuri, Terezinha Marta Pereira Pinto Castiñeiras, Átila Duque Rossi, Cynthia Chester Cardoso   +15 more
wiley   +1 more source

Editorial: Drug discovery for leishmaniasis and chagas disease: compound design and therapeutic strategies. [PDF]

Front Pharmacol
Kalesh K, Barbosa EG, Jordão AK.
europepmc   +1 more source

Bioactivity Profiles of Progressively Ring‐Fluorinated Cyclohexyl Motifs in the WKYMVm Peptide as Formylpeptide FPR2 Agonists and in Keto‐Piperazines as Antitrypanosome Agents

ChemBioChem, Volume 26, Issue 22, November 17, 2025.
All‐cis‐fluorinated cyclohexyl motifs with progressively increasing levels of fluorine are introduced into the WKYMVm peptide and a class of keto‐piperazine derivatives and assayed against the FPR2 receptor or the parasite Trypanosoma brucei, respectively.
Mengfan He, Christina M. Thomson, Dawn Thompson, Vytautus Kuodis, Terry K. Smith, Sergio Dall’Angelo, David O’Hagan   +6 more
wiley   +1 more source

Chagas Disease in the 21st Century: Global Spread, Ecological Shifts, and Research Frontiers. [PDF]

Biology (Basel)
Ferreira MDS, Maldonado RA, Farani PSG.
europepmc   +1 more source

The impact of temperature on canine Chagas disease transmission risk: A modeling study. [PDF]

PLoS Negl Trop Dis
Fiatsonu E, Mokhtar S, Ndeffo-Mbah ML.
europepmc   +1 more source

Chagas disease in Brazil: new challenges and perspectives for old problems. [PDF]

Mem Inst Oswaldo Cruz
Santos FLN, Costa VMD, Silva RAE.
europepmc   +1 more source

Myocardial work in Chagas disease: comparative analysis with conventional parameters in different cardiac clinical stages. [PDF]

Front Cardiovasc Med
Felix ADS, Kasal DAB, Lustosa RP, Bittencourt MI, Spineti PPM, Wajsbrot BR, Castier MB, Mourilhe-Rocha R.   +7 more
europepmc   +1 more source

Economic burden of Chagas disease in Brazil: a nationwide cost-of-illness study. [PDF]

Lancet Reg Health Am
Andrade MV, Noronha KVMS, de Souza A, Julião NA, Motta-Santos AS, Braga PEF, Bracarense H, Silva YC, Nascimento BR, Carneiro M, Martins-Melo FR, Machado IE, Perel P, Geissbühler Y, Demacq C, Ribeiro ALP.   +15 more
europepmc   +1 more source

Community-based serological screening for Chagas disease in London: a cross-sectional, observational pilot study. [PDF]

BMJ Public Health
Elkheir N, Sanchez Zelaya L, Valderrama Penagos L, Lopez L, Ville R, Sienra-Iracheta E, Fisayo T, Lok P, Ryan F, Bayona A, Garcia Romero J, Warrell CE, Massie N, Fernandez-Turienzo C, De Sario V, Abaakouk J, Guzman Miranda K, Alfulaij A, Suarez C, Loader MC, Dominic C, Melo MD, Costa Marinho M, Segura MB, Gerber H, Bote-Casamitjana A, Miralhes P, Chase-Vilchez A, Crilly D, Wilson-Goldsmith J, de Barros B, Carter J, Liddy H, Murphy N, Nolder D, Bustinduy A, Nabarro LE, Chiodini PL, Moore D.   +38 more
europepmc   +1 more source